MANF Therapeutics to evaluate strategic options to
Post# of 30028
(Total Views: 381)
Posted On: 04/17/2017 9:12:18 AM
Re: jamiejaytrader #24793
Quote:
MANF Therapeutics to evaluate strategic options to complete Investigational New Drug (IND) enabling pre-clinical studies ahead of a first-in-man clinical trial
This is pretty significant!
MANF has always been the golden egg (or is it goose?) of the company!
Getting this in human studies is going to do wonders for the pps!
Our market value should go up as soon as the IND is ready to be filed.
just my opinion from my own experience.
(4)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼